Last updated: December 13, 2022
Sponsor: Centre Hospitalier Universitaire, Amiens
Overall Status: Active - Recruiting
Phase
N/A
Condition
Soft Tissue Infections
Kidney Disease
Renal Failure
Treatment
N/AClinical Study ID
NCT05659589
PI2021_843_0143
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age over 18 years old.
- Patients hospitalized in conventional hospital departments and in intensive care unitsof nephrology.
- Patients with moderate to severe AKI (KDIGO 2 or 3) without dialysis.
- AKI from functional or organic aetiology
Exclusion
Exclusion Criteria:
- Patients with severe CKD (GFR<45ml/min/1.73 m2) or with kidney transplants.
- Patients with AKI from septic or obstructive aetiology.
- Patients with AKI from toxic aetiology whose toxic would be also responsable of cardiatoxicity.
- Patients with sepsis or blood inflammation.
- Patients with severe chronic cardia dysfunction.
- Patients with arrhythmia or complete heart block.
- Patients with peripheral artery occlusive disease.
- Pregnancy.
- Patients on palliative care.
Study Design
Total Participants: 150
Study Start date:
December 13, 2022
Estimated Completion Date:
December 31, 2025
Connect with a study center
Amiens hospital
Amiens, 80000
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.